29.71
price down icon0.87%   -0.26
 
loading

Alkermes Plc Aktie (ALKS) Neueste Nachrichten

pulisher
Dec 20, 2024

Expansion Therapeutics Names Elliot Ehrich, MD, Chief Medical Officer - Marketscreener.com

Dec 20, 2024
pulisher
Dec 20, 2024

Alkermes pays off and terminates major credit agreement By Investing.com - Investing.com Canada

Dec 20, 2024
pulisher
Dec 20, 2024

2025 will be a big year for Mural Oncology's drugs in development - The Business Journals

Dec 20, 2024
pulisher
Dec 20, 2024

Alkermes pays off and terminates major credit agreement - Investing.com

Dec 20, 2024
pulisher
Dec 20, 2024

Tidal Investments LLC Invests $1.10 Million in Alkermes plc (NASDAQ:ALKS) - MarketBeat

Dec 20, 2024
pulisher
Dec 19, 2024

Alkermes Prepares for New Flexibility Post Credit Termination - TipRanks

Dec 19, 2024
pulisher
Dec 19, 2024

Geode Capital Management LLC Sells 60,037 Shares of Alkermes plc (NASDAQ:ALKS) - MarketBeat

Dec 19, 2024
pulisher
Dec 17, 2024

We Think Alkermes (NASDAQ:ALKS) Can Stay On Top Of Its Debt - Simply Wall St

Dec 17, 2024
pulisher
Dec 16, 2024

Wilmington Savings Fund Society FSB Invests $582,000 in Alkermes plc (NASDAQ:ALKS) - MarketBeat

Dec 16, 2024
pulisher
Dec 16, 2024

Barclays PLC Boosts Holdings in Alkermes plc (NASDAQ:ALKS) - MarketBeat

Dec 16, 2024
pulisher
Dec 14, 2024

Alkermes To Take Part In The Fourth Annual Evercore ISI Healthconx Conference - Environmental Expert

Dec 14, 2024
pulisher
Dec 13, 2024

Opioid Use Disorder Market: Share, Key Trends, Growth Drivers, - openPR

Dec 13, 2024
pulisher
Dec 12, 2024

When (ALKS) Moves Investors should Listen - Stock Traders Daily

Dec 12, 2024
pulisher
Dec 12, 2024

Fmr LLC Has $9.71 Million Stake in Alkermes plc (NASDAQ:ALKS) - MarketBeat

Dec 12, 2024
pulisher
Dec 11, 2024

State Street Corp Lowers Stake in Alkermes plc (NASDAQ:ALKS) - MarketBeat

Dec 11, 2024
pulisher
Dec 11, 2024

Alkermes plc (NASDAQ:ALKS) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat

Dec 11, 2024
pulisher
Dec 10, 2024

Alkermes' EVP Craig Hopkinson sells shares worth $1.96 million By Investing.com - Investing.com South Africa

Dec 10, 2024
pulisher
Dec 10, 2024

Frazier Life Sciences Management L.P. Acquires New Stake in Alkermes plc (NASDAQ:ALKS) - MarketBeat

Dec 10, 2024
pulisher
Dec 09, 2024

Alkermes director Cato Laurencin sells $85,708 in stock By Investing.com - Investing.com Canada

Dec 09, 2024
pulisher
Dec 09, 2024

Alkermes' EVP Craig Hopkinson sells shares worth $1.96 million - Investing.com

Dec 09, 2024
pulisher
Dec 08, 2024

Wellington Management Group LLP Sells 1,696,507 Shares of Alkermes plc (NASDAQ:ALKS) - MarketBeat

Dec 08, 2024
pulisher
Dec 08, 2024

Alkermes plc (NASDAQ:ALKS) Stake Lifted by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - MarketBeat

Dec 08, 2024
pulisher
Dec 06, 2024

Insider Sell: Craig Hopkinson Sells 9,221 Shares of Alkermes PLC (ALKS) - GuruFocus.com

Dec 06, 2024
pulisher
Dec 06, 2024

Alkermes' chief medical officer sells $290,461 in stock By Investing.com - Investing.com Australia

Dec 06, 2024
pulisher
Dec 05, 2024

Alkermes' chief medical officer sells $290,461 in stock - Investing.com India

Dec 05, 2024
pulisher
Dec 05, 2024

Insider Sell: Craig Hopkinson Sells 14,349 Shares of Alkermes PL - GuruFocus.com

Dec 05, 2024
pulisher
Dec 05, 2024

RTW Investments LP Sells 402,955 Shares of Alkermes plc (NASDAQ:ALKS) - MarketBeat

Dec 05, 2024
pulisher
Dec 05, 2024

BNP Paribas Financial Markets Buys 63,939 Shares of Alkermes plc (NASDAQ:ALKS) - MarketBeat

Dec 05, 2024
pulisher
Dec 04, 2024

Alkermes EVP and chief medical officer sells shares worth $441,550 By Investing.com - Investing.com Canada

Dec 04, 2024
pulisher
Dec 04, 2024

Alkermes EVP and chief medical officer sells shares worth $441,550 - Investing.com

Dec 04, 2024
pulisher
Dec 04, 2024

Alkermes PLC (ALKS) Shares Up 4.58% on Dec 4 - GuruFocus.com

Dec 04, 2024
pulisher
Dec 03, 2024

Drug Addiction Treatment Market Future Business Opportunities - openPR

Dec 03, 2024
pulisher
Dec 01, 2024

Citigroup Inc. Buys 65,536 Shares of Alkermes plc (NASDAQ:ALKS) - MarketBeat

Dec 01, 2024
pulisher
Nov 30, 2024

Charles Schwab Investment Management Inc. Has $58.98 Million Stock Position in Alkermes plc (NASDAQ:ALKS) - MarketBeat

Nov 30, 2024
pulisher
Nov 29, 2024

Public Sector Pension Investment Board Reduces Position in Alkermes plc (NASDAQ:ALKS) - MarketBeat

Nov 29, 2024
pulisher
Nov 29, 2024

Fisher Asset Management LLC Acquires 18,147 Shares of Alkermes plc (NASDAQ:ALKS) - MarketBeat

Nov 29, 2024
pulisher
Nov 29, 2024

Alkermes plc (NASDAQ:ALKS) Stock Position Reduced by Connor Clark & Lunn Investment Management Ltd. - MarketBeat

Nov 29, 2024
pulisher
Nov 27, 2024

Insider Sell: Christian Nichols Sells Shares of Alkermes PLC - GuruFocus.com

Nov 27, 2024
pulisher
Nov 27, 2024

Alkermes SVP Nichols sells $151,813 in stock By Investing.com - Investing.com Nigeria

Nov 27, 2024
pulisher
Nov 27, 2024

Alkermes SVP Nichols sells $151,813 in stock - Investing.com India

Nov 27, 2024
pulisher
Nov 27, 2024

Pathstone Holdings LLC Has $2 Million Stake in Alkermes plc (NASDAQ:ALKS) - MarketBeat

Nov 27, 2024
pulisher
Nov 27, 2024

Natixis Advisors LLC Increases Position in Alkermes plc (NASDAQ:ALKS) - MarketBeat

Nov 27, 2024
pulisher
Nov 26, 2024

Axsome Therapeutics eyes approval after Phase III narcolepsy win - Clinical Trials Arena

Nov 26, 2024
pulisher
Nov 26, 2024

Loomis Sayles & Co. L P Purchases 1,478,422 Shares of Alkermes plc (NASDAQ:ALKS) - MarketBeat

Nov 26, 2024
pulisher
Nov 26, 2024

Intech Investment Management LLC Buys New Shares in Alkermes plc (NASDAQ:ALKS) - MarketBeat

Nov 26, 2024
pulisher
Nov 25, 2024

Alkermes to Participate in Upcoming Investor Conferences - StreetInsider.com

Nov 25, 2024
pulisher
Nov 24, 2024

Alkermes: Products Sales, ALKS 2680 Can Still Drive Long-Term Growth - Seeking Alpha

Nov 24, 2024
pulisher
Nov 24, 2024

Eagle Asset Management Inc. Trims Holdings in Alkermes plc (NASDAQ:ALKS) - MarketBeat

Nov 24, 2024
pulisher
Nov 23, 2024

Victory Capital Management Inc. Grows Position in Alkermes plc (NASDAQ:ALKS) - MarketBeat

Nov 23, 2024
$11.63
price down icon 1.61%
$89.28
price down icon 2.89%
$83.45
price down icon 0.82%
drug_manufacturers_specialty_generic RDY
$15.37
price up icon 1.65%
$135.42
price up icon 0.34%
$12.52
price up icon 3.22%
Kapitalisierung:     |  Volumen (24h):